Although primary pulmonary hypertension (PPH) is considered to be an i
diopathic condition, it has been postulated that autoimmunity may play
a role in the pathogenesis of the disease. This argument has been bas
ed on frequent coexisting clinical and serological rheumatic findings.
Moreover, approximately in a third of the patients with PPH, and anti
nuclear factor can be detected. Pulmonary hypertension may appear as a
secondary complication to various autoimmune conditions. In light of
these findings we examined sera derived from 40 patients diagnosed as
having PPH for the presence of 18 different autoantibodies by the ELIS
A and immunofluorescent techniques. Of the 40 patients, 62.4% had circ
ulating autoantibodies and 47.5% presented with multiantibody response
s. Autoantibodies most commonly observed were antinuclear (42.5%), ant
i-ssDNA (25%) and antithyroglobulin (30%) antibodies. These results ma
y imply that in a subgroup of patients with PPH the disease may be asc
ribed to an immune dysregulation or alternatively that autoantibodies
accompany the disease progression as an epiphenomenon.